68Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer

被引：0
|
作者：
Jonathan Damjanovic
Jan-Carlo Janssen
Christian Furth
Gerd Diederichs
Thula Walter
Holger Amthauer
Marcus R. Makowski
机构：
[1] Department of Radiology,
[2] Charité,undefined
[3] Department of Nuclear Medicine,undefined
[4] Charité,undefined
[5] King’s College London,undefined
[6] Division of Imaging Sciences,undefined
来源：
Cancer Imaging | / 18卷
关键词：
Lung metastasis, Pulmonary opacity, PSMA, PET/CT, Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
    Freitag, Martin T.
    Radtke, Jan P.
    Hadaschik, Boris A.
    Kopp-Schneider, A.
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    Roethke, Matthias
    Schlemmer, Heinz-Peter
    Afshar-Oromieh, Ali
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 70 - 83
  • [32] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
    Martin T. Freitag
    Jan P. Radtke
    Boris A. Hadaschik
    A. Kopp-Schneider
    Matthias Eder
    Klaus Kopka
    Uwe Haberkorn
    Matthias Roethke
    Heinz-Peter Schlemmer
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 70 - 83
  • [33] Contribution of 68GA-PSMA-PET/CT to Risk Classification In Prostate Cancer With Gleason Score 6
    Sahin, O.
    Beyhan, E.
    Fenercioglu, O. E.
    Arslan, E.
    Cermik, T. F.
    Ergul, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S522 - S522
  • [34] Evaluation of 68Ga-PSMA PET/CT in patients with Biochemical Recurrence of Prostate Cancer
    Dyankova, M.
    Stoeva, T.
    Dancheva, Z.
    Yordanova, T.
    Chausheva, S.
    Chaushev, B.
    Klisarova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S450 - S451
  • [35] (68Ga) gallium-PSMA PET/CT in the evaluation of prostate cancer patients
    Bal, C.
    Ballal, S.
    Tripati, M.
    Chakraborty, P.
    Thakral, P.
    Arora, G.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [36] Ga-68-PSMA PET/CT for Prostate Cancer
    Hellwig, D.
    Moosbauer, J.
    Eilles, C.
    AKTUELLE UROLOGIE, 2014, 45 (06) : 457 - 463
  • [37] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [38] 68Ga-PSMA-PET/CT and bone scintigraphy imaging for staging of high-risk prostate cancer
    Lengana, Thabo
    Modiselle, Moshe
    Lawal, Ismaheel
    Boshomane, Gill
    Ebenhan, Thomas
    Vorster, Mariza
    Sathekge, Machaba
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [39] Ga-68 PSMA PET/CT in postoperative Prostate Cancer patients
    Alongi, F.
    Mazzola, R.
    Fersino, S.
    Aiello, D.
    Fiorentino, A.
    Gregucci, F.
    Levra, N. Giaj
    Ricchetti, F.
    Salgarello, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S833 - S833
  • [40] The role of 68Ga-PSMA-PET/CT for identification of high-malignant intraprostatic cancer lesions in 104 prostate cancer patients
    Koerber, S. A.
    Utzinger, M.
    Krug, D.
    Kratochwil, C.
    Haefner, M. F.
    Katayama, S.
    Herfarth, K.
    Haberkorn, U.
    Debus, J.
    Giesel, F. L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S136 - S136
12345